nodes	percent_of_prediction	percent_of_DWPC	metapath
Nabumetone—MPO—endothelium—focal segmental glomerulosclerosis	0.0432	0.273	CbGeAlD
Nabumetone—Bullous eruption—Cyclosporine—focal segmental glomerulosclerosis	0.0428	0.0508	CcSEcCtD
Nabumetone—PTGS2—nephron—focal segmental glomerulosclerosis	0.0415	0.262	CbGeAlD
Nabumetone—Azotaemia—Cyclosporine—focal segmental glomerulosclerosis	0.0317	0.0377	CcSEcCtD
Nabumetone—Gastric ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.0291	0.0346	CcSEcCtD
Nabumetone—Peptic ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.0253	0.0301	CcSEcCtD
Nabumetone—Interstitial lung disease—Cyclosporine—focal segmental glomerulosclerosis	0.0239	0.0284	CcSEcCtD
Nabumetone—Gingivitis—Cyclosporine—focal segmental glomerulosclerosis	0.0216	0.0256	CcSEcCtD
Nabumetone—PTGS1—endothelium—focal segmental glomerulosclerosis	0.0205	0.129	CbGeAlD
Nabumetone—Acne—Cyclosporine—focal segmental glomerulosclerosis	0.0201	0.0239	CcSEcCtD
Nabumetone—PTGS2—endothelium—focal segmental glomerulosclerosis	0.0196	0.124	CbGeAlD
Nabumetone—Rectal haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.0187	0.0222	CcSEcCtD
Nabumetone—Glossitis—Cyclosporine—focal segmental glomerulosclerosis	0.0184	0.0218	CcSEcCtD
Nabumetone—Hyperuricaemia—Cyclosporine—focal segmental glomerulosclerosis	0.0182	0.0217	CcSEcCtD
Nabumetone—MPO—kidney—focal segmental glomerulosclerosis	0.0174	0.11	CbGeAlD
Nabumetone—Blood uric acid increased—Cyclosporine—focal segmental glomerulosclerosis	0.0172	0.0205	CcSEcCtD
Nabumetone—Eructation—Cyclosporine—focal segmental glomerulosclerosis	0.0166	0.0197	CcSEcCtD
Nabumetone—Nightmare—Cyclosporine—focal segmental glomerulosclerosis	0.0163	0.0194	CcSEcCtD
Nabumetone—Abnormal vision—Cyclosporine—focal segmental glomerulosclerosis	0.0148	0.0175	CcSEcCtD
Nabumetone—Gastroenteritis—Cyclosporine—focal segmental glomerulosclerosis	0.0139	0.0165	CcSEcCtD
Nabumetone—Hepatic failure—Cyclosporine—focal segmental glomerulosclerosis	0.0137	0.0162	CcSEcCtD
Nabumetone—Increased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.0131	0.0155	CcSEcCtD
Nabumetone—Dermatitis bullous—Cyclosporine—focal segmental glomerulosclerosis	0.0128	0.0153	CcSEcCtD
Nabumetone—Anaphylactoid reaction—Cyclosporine—focal segmental glomerulosclerosis	0.0127	0.0151	CcSEcCtD
Nabumetone—Gastritis—Cyclosporine—focal segmental glomerulosclerosis	0.0109	0.0129	CcSEcCtD
Nabumetone—Dysphagia—Cyclosporine—focal segmental glomerulosclerosis	0.0106	0.0126	CcSEcCtD
Nabumetone—Pancreatitis—Cyclosporine—focal segmental glomerulosclerosis	0.0104	0.0124	CcSEcCtD
Nabumetone—Sweating increased—Cyclosporine—focal segmental glomerulosclerosis	0.0103	0.0123	CcSEcCtD
Nabumetone—Dysuria—Cyclosporine—focal segmental glomerulosclerosis	0.00992	0.0118	CcSEcCtD
Nabumetone—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.00966	0.0115	CcSEcCtD
Nabumetone—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.0096	0.0114	CcSEcCtD
Nabumetone—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00957	0.0114	CcSEcCtD
Nabumetone—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.00952	0.0113	CcSEcCtD
Nabumetone—Depression—Cyclosporine—focal segmental glomerulosclerosis	0.00944	0.0112	CcSEcCtD
Nabumetone—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.00933	0.0111	CcSEcCtD
Nabumetone—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.0093	0.0111	CcSEcCtD
Nabumetone—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.00928	0.011	CcSEcCtD
Nabumetone—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00922	0.011	CcSEcCtD
Nabumetone—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.00922	0.011	CcSEcCtD
Nabumetone—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.00902	0.0107	CcSEcCtD
Nabumetone—Haemoglobin—Cyclosporine—focal segmental glomerulosclerosis	0.00854	0.0101	CcSEcCtD
Nabumetone—Haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00849	0.0101	CcSEcCtD
Nabumetone—PTGS1—kidney—focal segmental glomerulosclerosis	0.00824	0.0521	CbGeAlD
Nabumetone—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00819	0.00972	CcSEcCtD
Nabumetone—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.00792	0.00941	CcSEcCtD
Nabumetone—PTGS2—kidney—focal segmental glomerulosclerosis	0.00788	0.0498	CbGeAlD
Nabumetone—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.00762	0.00905	CcSEcCtD
Nabumetone—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.00759	0.00901	CcSEcCtD
Nabumetone—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.00751	0.00892	CcSEcCtD
Nabumetone—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.00729	0.00866	CcSEcCtD
Nabumetone—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.00726	0.00862	CcSEcCtD
Nabumetone—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.00718	0.00853	CcSEcCtD
Nabumetone—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.00693	0.00823	CcSEcCtD
Nabumetone—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00686	0.00815	CcSEcCtD
Nabumetone—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00683	0.00812	CcSEcCtD
Nabumetone—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.0068	0.00807	CcSEcCtD
Nabumetone—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.00676	0.00803	CcSEcCtD
Nabumetone—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.00667	0.00792	CcSEcCtD
Nabumetone—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.00664	0.00789	CcSEcCtD
Nabumetone—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00662	0.00786	CcSEcCtD
Nabumetone—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.00645	0.00767	CcSEcCtD
Nabumetone—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.00638	0.00758	CcSEcCtD
Nabumetone—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.00627	0.00745	CcSEcCtD
Nabumetone—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00622	0.00739	CcSEcCtD
Nabumetone—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.00616	0.00731	CcSEcCtD
Nabumetone—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.00609	0.00723	CcSEcCtD
Nabumetone—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.00604	0.00717	CcSEcCtD
Nabumetone—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.00604	0.00717	CcSEcCtD
Nabumetone—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00591	0.00702	CcSEcCtD
Nabumetone—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.00583	0.00693	CcSEcCtD
Nabumetone—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.00575	0.00683	CcSEcCtD
Nabumetone—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00546	0.00648	CcSEcCtD
Nabumetone—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00542	0.00644	CcSEcCtD
Nabumetone—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00538	0.00639	CcSEcCtD
Nabumetone—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.00537	0.00637	CcSEcCtD
Nabumetone—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.00531	0.00631	CcSEcCtD
Nabumetone—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00525	0.00623	CcSEcCtD
Nabumetone—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.0052	0.00618	CcSEcCtD
Nabumetone—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.00516	0.00613	CcSEcCtD
Nabumetone—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00497	0.00591	CcSEcCtD
Nabumetone—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00494	0.00586	CcSEcCtD
Nabumetone—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.00479	0.0057	CcSEcCtD
Nabumetone—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.00477	0.00567	CcSEcCtD
Nabumetone—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00477	0.00567	CcSEcCtD
Nabumetone—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.00445	0.00528	CcSEcCtD
Nabumetone—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.00433	0.00514	CcSEcCtD
Nabumetone—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.00427	0.00507	CcSEcCtD
Nabumetone—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00413	0.00491	CcSEcCtD
Nabumetone—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.00399	0.00474	CcSEcCtD
Nabumetone—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00384	0.00456	CcSEcCtD
Nabumetone—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.00381	0.00452	CcSEcCtD
Nabumetone—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.0038	0.00452	CcSEcCtD
Nabumetone—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.00378	0.00449	CcSEcCtD
Nabumetone—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.00358	0.00426	CcSEcCtD
